MCR Compounds (AcurePharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMCR Compounds (AcurePharma)
Drug Alias NameAM-240 MCRAP-102 (AcurePharma/AnaMar Medical)anti-inflammatory/immunomodulatory compounds (AnaMar Medical)melanocortin 1 receptor agonists (Melacure)MCR Compounds (AcurePharma/AnaMar Medical) +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 1 agonists
TargetsMelanocortin receptor 1
Therapy Area/IndicationsInflammationImmune System DiseasesOsteoarthritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMelacure Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMar-MedMelacure Therapeutics ABAcure Pharma AB
Active IndicationsN/A
Inactive IndicationsInflammationImmune System DiseasesOsteoarthritis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A